Company intelligence / Profile preview

M28 Capital Management

Stamford, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

M28 Capital Management is a U.S.-based investment management firm focused on the healthcare, biotechnology, and pharmaceutical sectors. The firm runs a long/short equity strategy and also manages private funds that invest in life sciences companies. It is led by founder Marc Elia and is based in Stamford, Connecticut. Rather than developing therapeutics itself, M28 Capital allocates capital to public and private companies positioned to benefit from advances in biotechnology and human health. The firm appears to operate as a healthcare-focused investment platform rather than a drug developer, with exposure to biotech through portfolio holdings and venture investments.

Industry: Investors

Beyond the preview

Go deeper on M28 Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M28 Capital Management.

Explore the full profile